Oops! This Content is Members Only

Recent Content

• Embracing Myeloma Chimeric Antigen Receptor-T: From Scientific Design to Clinical Impact
• Bilateral Exudative Retinal Detachments and Panuveitis in a Patient with Multiple Myeloma
• FDA Lifts Partial Clinical Hold on Phase 1 Trial of MT-0169 in Multiple Myeloma, Hodgkin Lymphoma
• Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies: a pharmacovigilance analysis
• Starving multiple myeloma cells via CDK7 inhibition
• Semistructured Patient Interviews Identify Facilitators of MM Treatment Initiation, Continuation
• Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma
• Severe laryngeal edema after CAR-T cell treatment in a patient with multiple myeloma: A case report
• Re-expansion of vertebral compression fractures in patients with multiple myeloma with percutaneous vertebroplasty using spinejack implants: a preliminary and retrospective study
• Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis